Jiaqi Lou | Clinical medicine | Best Researcher Award

Dr. Jiaqi Lou | Clinical medicine | Best Researcher Award

Dr. Jiaqi Lou, Ningbo No.2 Hospital, China

Lou Jiaqi, born on May 16, 1995, is a dedicated burn surgeon and researcher specializing in intestinal mucosal healing post-burn injury. He holds a Master’s degree in Burns/Surgery from Xuzhou Medical University (2019-2022) and a Bachelor’s degree in Clinical Medicine from Wenzhou Medical University Renji College (2013-2018). Currently, he serves as a Resident at Ningbo No.2 Hospital’s Department of Burns. His research focuses on circular and long non-coding RNAs in burn-induced intestinal damage, nutritional strategies for burn patients, and predictive modeling in burn care. With multiple publications in high-impact journals like Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology, he has significantly contributed to advancing burn treatment methodologies. Proficient in molecular biology and bioinformatics, he actively integrates clinical practice with translational research, enhancing patient outcomes. His expertise extends to animal models, clinical nutrition, and machine learning applications in burn medicine.

Publication Profile

Scopus

Orcid

Education 🎓📚

Lou Jiaqi pursued his Bachelor’s degree in Clinical Medicine at Wenzhou Medical University Renji College (2013-2018), where he gained a solid foundation in medical sciences and clinical practice. Following this, he completed his Master’s degree in Burns/Surgery at Xuzhou Medical University (2019-2022), focusing on post-burn intestinal mucosal healing and advanced molecular techniques. His postgraduate research centered on exploring the role of circular RNAs and long non-coding RNAs in burn-induced intestinal injury, utilizing qRT-PCR, bioinformatics analysis, and adenoviral transfection techniques. He also conducted extensive studies on enteral and parenteral nutrition strategies for burn patients, integrating randomized controlled trials and systematic reviews. Throughout his academic journey, he actively engaged in laboratory and clinical research, refining his expertise in molecular biology, protein interactions, and animal modeling. His strong academic background, combined with hands-on research and clinical exposure, has shaped him into a proficient clinician-scientist in burn medicine.

Experience 🏥

Lou Jiaqi is a Resident at the Department of Burns, Ningbo No.2 Hospital (2022-present), where he manages burn patient care and conducts translational research. Previously, he served as a Resident at The Affiliated Huaihai Hospital of Xuzhou Medical University and The 71st Group Army Hospital of PLA (2019-2022), gaining extensive experience in burn surgery and post-burn recovery. His clinical training began with rotations at leading hospitals, including Minhang Hospital and The First Affiliated Hospital of Wenzhou Medical University (2016-2018). During his early medical career, he interned at Ningbo No.1 Hospital’s Burn Department, refining his hands-on patient care and surgical skills. His experience spans acute burn management, surgical interventions, intensive care, and nutritional strategies for burn patients. Alongside his clinical duties, he integrates machine learning and predictive modeling to enhance patient outcomes, positioning himself at the forefront of innovative burn treatment methodologies.

Awards & Honors 🏆🎖️

Lou Jiaqi has received several accolades for his contributions to burn medicine and research. He was awarded the Certificate of Resident Standardization Training of China (2024), recognizing his advanced clinical expertise. His achievements in molecular biology and burn research have been acknowledged through multiple journal publications, including in Cell Biology International, Cell Death & Disease, and Burns & Trauma. He obtained the Medical Practitioners Qualification of China (2021) and the Basic Life Support Provider Certification (2022), demonstrating his commitment to patient safety and professional excellence. His studies on burn-induced intestinal injury and nutritional optimization in burn patients have earned him recognition in both national and international medical communities. With a strong research background, he has contributed to advancements in RNA-based therapies and predictive modeling, enhancing patient outcomes. His extensive training, combined with a passion for innovation, has solidified his reputation as a promising burn surgeon and scientist.

Research Focus 🔬🧬

Lou Jiaqi specializes in burn-induced intestinal mucosal healing, investigating the role of circular and long non-coding RNAs in post-burn intestinal injury. His research includes circRNA-mediated signaling pathways, ceRNA network modeling, and RNA-binding protein interactions to enhance tissue repair mechanisms. He has explored enteral and parenteral nutritional strategies to optimize burn patient recovery, conducting randomized controlled trials and systematic reviews. His expertise extends to molecular and cellular techniques such as qRT-PCR, Western blotting, ELISA, and dual-luciferase assays. Additionally, he applies machine learning and Mendelian randomization in predictive modeling for burn patient outcomes. His studies have led to significant publications in Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology. By integrating basic science, clinical practice, and bioinformatics, he contributes to innovative therapeutic approaches in burn care, focusing on translational medicine and personalized treatment strategies for severe burn patients.

 

Publication Top Notes

  • “A Bidirectional Mendelian-Randomization Analyses of Genetically Predicted Circulating Levels of Systemic Inflammatory Regulators with Risk of Sepsis” (2024) examines genetic predictors of systemic inflammation and their association with sepsis risk.

  • “Development, Reliability, and Validity of the Second-Modified Nutrition Risk Screening 2002” (2024) focuses on enhancing nutritional risk screening tools for clinical settings.

  • “The Efficacy and Safety of Negative Pressure Wound Therapy in Paediatric Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” (2024) evaluates the effectiveness of negative pressure wound therapy in treating pediatric burn patients.

  • “A Two-Step, Two-Sample Mendelian Randomization Analysis Investigating the Interplay Between Gut Microbiota, Immune Cells, and Melanoma Skin Cancer” (2024) investigates the relationship between gut microbiota, immune response, and melanoma development.

  • “A Retrospective Study Utilizing MIMIC-IV Database to Explore the Potential Association Between Triglyceride-Glucose Index and Mortality in Critically Ill Patients with Sepsis” (2024) explores the link between triglyceride-glucose index levels and mortality rates in septic patients.

  • “Effects of Virtual Reality on Analgesia in Wound Care and Physical Therapy for Burn Patients: A Systematic Review and Meta-Analysis” (2024) assesses the use of virtual reality for pain management in burn care.

  • “Development and Validation of a Nomogram to Predict Hypothermia in Adult Burn Patients During Escharectomy Under General Anesthesia” (2024) introduces a predictive tool for hypothermia during specific surgical procedures in burn patients.

  • “Efficacy of Probiotics or Synbiotics in Critically Ill Patients: A Systematic Review and Meta-Analysis” (2024) examines the benefits of probiotics or synbiotics in critically ill patients.

  • “Causal Relationship Between the Gut Microbiome and Basal Cell Carcinoma, Melanoma Skin Cancer, Ease of Skin Tanning: Evidence from Three Two-Sample Mendelian Randomisation Studies” (2024) explores the causal links between the gut microbiome and various skin conditions.

  • “PRP8-Induced CircMaml2 Facilitates the Healing of the Intestinal Mucosa via Recruiting PTBP1 and Regulating Sec62” (2022) investigates molecular mechanisms involved in intestinal mucosal healing.

 

 

Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Oswaldo Aguilar | Medicine and Dentistry | Best Researcher Award

Dr Oswaldo Aguilar, Universidad del Valle, Colombia

Dr. Oswaldo Aguilar 🩺❤️ is a cardiologist and echocardiography specialist at Hospital Universitario del Valle, Colombia. He also serves as a lecturer at Universidad del Valle and Universidad Libre. Dr. Aguilar holds a medical degree from Universidad Rafael Núñez and specialized in Internal Medicine and Clinical Cardiology. A prolific author, he has contributed to key medical textbooks and journals 📚. He is a member of the American College of Physicians, the Sociedad Colombiana de Cardiología, and ESC. Passionate about cardiovascular imaging and heart failure research, Dr. Aguilar actively shapes future medical professionals through teaching and mentorship. 🎓💉

Publication Profile

Scopus

Clinical Expertise and Teaching

Dr. Oswaldo Aguilar is a dedicated cardiologist and medical educator 🩺❤️. Since January 2024, he has worked at Hospital Universitario del Valle in advanced cardiac imaging. He also teaches postgraduate internal medicine and cardiology at Universidad del Valle and Universidad Libre, Cali 👨‍🏫. Dr. Aguilar has been a cardiologist at Colsanitas S.A. since 2022. Previously, he completed a cardiology fellowship at Universidad de Antioquia and practiced internal medicine at Hospital Universitario del Valle and Fundación Valle de Lili 🏥. His experience spans urgent care, hospital wards, and intensive care, showcasing his commitment to patient care and medical training.

Complementaria

Dr. Oswaldo Aguilar is a dedicated cardiologist with advanced training in cardiovascular imaging and clinical care ❤️‍🩹. He completed an ultrasound program for major syndromes at Universidad Cardenal Herrera (2019-2020) and holds diplomas in cardiovascular medicine 🫀 and clinical research 📊. His expertise spans heart failure management, anticoagulation, and pulmonary hypertension. He has extensive hands-on training, including a 2024 rotation in advanced cardiac imaging at Hospital Clínico San Carlos, Madrid 🏥. Certified in ACLS and trauma care, Dr. Aguilar is a Fellow in Training with the ACC (2020-2023) and proficient in POCUS imaging techniques 📈.

Recognition and Affiliations

Dr. Oswaldo Aguilar is a distinguished cardiologist with memberships in prestigious organizations, including the American College of Physicians 🩺, Sociedad Colombiana de Cardiología ❤️, and the European Society of Cardiology (ESC) 🌍. His affiliations reflect his dedication to advancing cardiovascular medicine and active participation in global cardiology networks. Dr. Aguilar’s involvement in these esteemed societies highlights his commitment to staying at the forefront of medical research and innovation, fostering collaboration with experts worldwide. Through these connections, he continually enhances his expertise, contributing to improved patient care and shaping the future of cardiology.

Research Focus

Dr. Oswaldo Aguilar’s research focuses on cardiovascular health 🫀, particularly in echocardiographic findings, aortic stenosis, heart failure, and coronary artery disease. His studies analyze systemic lupus erythematosus patients, mortality predictors, and atrial fibrillation treatments. Dr. Aguilar’s work spans retrospective cohort studies and practical reviews, emphasizing real-world applications in cardiology clinics and emergency rooms 🏥. His publications address critical issues like prosthetic valve thrombosis, aiming to improve patient outcomes through advanced diagnostic and therapeutic strategies. Dr. Aguilar’s contributions reflect a dedication to enhancing cardiovascular care and advancing knowledge in cardiology 📚❤️.

Publication Top Notes

Echocardiographic findings in patients with systemic lupus erythematosus: Retrospective analysis in a tertiary referral centre | Hallazgos ecocardiográficos en pacientes con lupus eritematoso sistémico: análisis retrospectivo en un centro de referencia terciaria

Low-Flow, Low-Gradient Severe Aortic Stenosis in patients with preserved or reduced ejection fraction: a systematic literature review.

Application of eligibility criteria from DAPA-HF, EMPEROR-Reduced, and PARADIGM-HF trials to a population with heart failure with reduced ejection fraction at a specialized cardiology Clinic in Medellin, Colombia: A retrospective cohort study

Atrial fibrillation treatment in the emergency room: a practical narrative review | Tratamiento de la fibrilación auricular en el servicio de urgencias: una revisión práctica de la literatura

Predictors of mortality in patients with coronary artery disease and involvement of the left main artery | Factores predictores de mortalidad en pacientes con enfermedad coronaria y compromiso del tronco principal izquierdo

Prosthetic valve thrombosis and thrombolytic therapy in the modern era: a case report | Trombosis valvular y terapia trombolítica en la era moderna: reporte de un caso

 

Haojie Shan | Medicine | Best Researcher Award

Haojie Shan | Medicine | Best Researcher Award

Resident Surgeon at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School, China.

Dr. Haojie Shan is a dedicated resident surgeon specializing in orthopaedics at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With a strong clinical and research foundation, Dr. Shan is passionate about advancing orthopaedic treatments, focusing on challenging areas such as osteonecrosis of the femoral head, bone immunity, and regeneration. His contributions to orthopaedics have been recognized through multiple prestigious awards, highlighting his commitment to innovation. Dr. Shan’s blend of clinical expertise and research excellence positions him as an emerging leader in orthopaedics, driven to enhance patient care and develop novel medical solutions.

Publication Profile

Scopus

Education

Dr. Shan completed his Ph.D. in Surgery (Orthopaedics) in 2023 at Shanghai Jiao Tong University, where he also earned his MD in 2020. He first obtained his Bachelor of Science in Clinical Medicine from Henan University in 2017. Each stage of his education has been marked by rigorous training, both in clinical practice and research, equipping him with a comprehensive understanding of orthopaedic medicine. This academic progression underscores Dr. Shan’s commitment to mastering complex medical challenges, particularly in his chosen field of orthopaedics, and provides a strong foundation for his clinical and research career.

Professional Experience

Currently, Dr. Shan is a resident surgeon in orthopaedics at Shanghai Sixth People’s Hospital. In this role, he has gained practical experience managing complex orthopaedic cases, with a focus on surgical techniques and postoperative care. His position at this leading hospital allows him to integrate his research insights with clinical practice, enhancing patient care with innovative approaches. His exposure to diverse cases has refined his skills in addressing issues like bone regeneration and infection control, which align with his research interests. Dr. Shan’s experience exemplifies his dedication to combining clinical expertise with research-driven improvements in orthopaedic care.

Research Focus

Dr. Shan’s research focuses on osteonecrosis of the femoral head, bone immunity, bone regeneration, and biomedical materials. His work seeks to address significant challenges in orthopaedic surgery, such as restoring bone function and preventing infection in complex cases. Dr. Shan is particularly interested in innovative treatments that promote healing and enhance patient outcomes. His research on bone and soft tissue infection and immunity explores the interactions between implants and the body’s immune response. Through his investigations, Dr. Shan aims to bridge scientific discovery and clinical application, advancing orthopaedic treatment methods and expanding therapeutic options in the field.

Awards and Honors

Dr. Shan has received multiple prestigious awards, reflecting his contributions to orthopaedics and medical innovation. In 2024, he won the Gold Award in the Shanghai Division and the National Silver Award at the International Innovation Competition for College Students in China. Additionally, he earned First Prize in the Rehabilitation Medicine and Engineering Innovation Competition (2023) and accolades for his papers at major conferences. His achievements also include third-place awards in the China Medical Device Innovation Competition and the Shanghai Orthopedics Annual Meeting. These recognitions underscore Dr. Shan’s dedication to advancing orthopaedic science and patient care.

Conclusion

Overall, Dr. Haojie Shan demonstrates strong qualifications for the “Best Researcher Award” based on his academic background, innovative research, and significant recognition within orthopaedics. Enhancing international visibility through collaborations and publications could further elevate his standing. Given his notable achievements and ongoing impact, he is a well-qualified candidate for the award.

Publication Top Notes 

Title: A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm
Authors: Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X.
Year: 2025
Journal: Carbohydrate Polymers, 347, 122723
Citations: 0

Title: Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections
Authors: Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X.
Year: 2024
Journal: Aggregate
Citations: 0

Title: An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing
Authors: Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C.
Year: 2024
Journal: Small Methods
Citations: 0

Title: Scd-1 deficiency promotes the differentiation of CD8+ T effector
Authors: Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X.
Year: 2024
Journal: Frontiers in Cellular and Infection Microbiology, 14, 1325390
Citations: 1

Title: Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways
Authors: Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X.
Year: 2023
Journal: Cell Proliferation, 56(11), e13485
Citations: 4

Title: Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α
Authors: Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T.
Year: 2023
Journal: Advanced Therapeutics, 6(3), 2200164
Citations: 2

Title: The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis
Authors: Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(4), pp. 240–245
Citations: 0

Title: Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination
Authors: Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(3), pp. 197–203
Citations: 0

Title: Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis
Authors: Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X.
Year: 2022
Journal: mSystems, 7(4)
Citations: 9

 

Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Prof Dr Hironori Tsujimoto National Defense Medical College, Japan

Prof. Dr. Hironori Tsujimoto’s education, professional experience, and research publications, he is indeed a strong candidate for the Best Researcher Award. His research in upper-gastrointestinal surgery, oncology, and innovative therapeutic techniques demonstrates significant contributions to the field. Below is a breakdown of his qualifications:

Publiacation Profile

orcid

Educational Background and Professional Experience

Prof. Dr. Tsujimoto graduated from the National Defense Medical College in 1993, completed his residency, and advanced his career through post-doctoral studies at both National Defense Medical College and the University of Florida. Since 2007, he has held key positions, including Assistant Professor and Director of Upper-gastrointestinal Surgery, contributing extensively to both surgical practice and research.

Research Contributions

Prof. Tsujimoto has consistently focused on cancer research, especially in gastrointestinal malignancies, lymph node metastasis, and therapeutic innovations. His research output, including publications in top journals, underscores his influence in the field. Some highlights include the study on high mobility group box chromosomal protein 1 expression in esophageal squamous cell carcinoma, published in Journal of Gastroenterology and Hepatology (2020). This work showed how perioperative protein levels impact long-term outcomes in cancer patients, advancing clinical management practices.

Membership

Prof. Tsujimoto is an active member of several prestigious medical organizations in Japan. These include the Japanese Surgical Society, the Japanese Society of Gastroenterological Surgery, and the Japanese Society for Clinical Surgery. Dr. [Name] also contributes to the Japanese Society for Surgical Metabolism and Nutrition, the Japan Shock Society, and the Japan Society for Endoscopic Surgery. Through these memberships, they stay at the forefront of surgical innovation and patient care, enhancing their expertise and contributing to the medical community.

Research

From 1993 to 2000, I served as a Research Associate at the Department of Surgery I, National Defense Medical College, under the guidance of Professor Mochizuki H. Since 2000, I have continued as a Research Associate at the same institution, now working in the Department of Surgery alongside Professor Hase K., with additional supervision by Professor Seki S. from the Department of Immunology and Microbiology. My research spans over two decades, contributing to advancements in surgical and immunological fields.

Publication Top Notes

Significance of resected stomach measurements in postoperative delayed gastric emptying following laparoscopic pylorus‐preserving gastrectom

ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma

Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth

Postoperative complications and impaired long‐term survival—Is this causation or association?

Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment

Conclusion

Prof. Dr. Hironori Tsujimoto’s contributions to surgical oncology and innovative cancer treatments underscore his suitability for the Best Researcher Award. His pioneering work on photodynamic therapy, novel surgical techniques, and understanding of cancer progression significantly advances gastrointestinal surgery and cancer care.

Sirous Sadeghian Chaleshtori | Inernal Medicine | Best Researcher Award

Assoc. Prof. Dr. Sirous Sadeghian Chaleshtori | Inernal Medicine | Best Researcher Award

Associate Professor of Tehran University, Iran

Sirous Sadeghian Chaleshtori, an Iranian national born on September 23, 1984, is a distinguished academic and Associate Professor of Large Animal Internal Medicine at the Faculty of Veterinary Medicine, University of Tehran. He also serves at the Institute of Biomedical Research within the same faculty. His career spans expertise in cardiovascular and pulmonary systems in animals, stem cells and regenerative medicine, as well as transplantation and cell therapy of stem cells.

Profile

Orcid

📚 Education 

Sirous excelled in his academic pursuits, earning recognition as an excellent student during his DVSc at the Faculty of Veterinary Medicine, University of Tehran in 2011. He continued to distinguish himself, culminating in awards such as the annual best student researches of University of Tehran in 2012 and the award for selected academic faculty member of Tehran University in 2022.

💼Professional experience

Sirous Sadeghian Chaleshtori’s professional journey is marked by his role as an Associate Professor, where he contributes significantly to the field of Large Animal Internal Medicine. His affiliation with the University of Tehran underscores his dedication to teaching and research, further enriched by his involvement in the Institute of Biomedical Research.

📋Research focus

His research interests focus on exploring the intricacies of cardiovascular and pulmonary systems in animals, advancing the frontiers of stem cells and regenerative medicine, and pioneering studies in transplantation and cell therapy using stem cells.

🏆 Awards and Recognition :

Sirous has been honored with prestigious awards, including the British Equine Veterinary Association’s World Award (The Peter Rossdale EVE Literary Award) in 2023, highlighting his global impact and contributions to veterinary science.

This consolidated biography encapsulates Sirous Sadeghian Chaleshtori’s academic achievements, professional journey, research interests, and notable recognitions.

📋🌍Publication Top Notes: 

1. Mohammad Ebrahim Mahaki, Sirous Sadeghian Chaleshtori*, Hasti Azarabad, Arman
Shokri. Omental lipoma in a slaughtered lamb. Iranian Journal of Veterinary Medicine.
Accept.
2. Marzieh Mokhber Dezfouli Zohre Eftekhari, Sirous Sadeghian Chaleshtori. The Effect of
Age and Gender on Natural Calves Lung Surfactant Function as a Valuable Therapeutic
Agent for Respiratory Distress Syndrome. Iranian Journal of Veterinary Medicine. Accept.
3. Sirous Sadeghian Chaleshtori, Mohammad Reza Mokber Dezfouli, Alireza Vajhi, Abolfazl
Najd Ghahremani, Neda Sabetzadeh, Javad Abbasi. Right parasternal echocardiographic
2
reference values in the healthymale Iranian Shall sheep. Veterinary Medicine and Science.
2024;10:e1535. (IF: 1.8 – Q2)
4. Hamid Tavanaeimanesh, Zahra Alinia, Sirous Sadeghian Chaleshtori, Hamidreza
Moosavian, Zeinab Mohebi, Mojtaba Daneshi. The efficacy of N-acetylcysteine in decreasing
airway inflammation and mucus accumulation in horses with 18 hours of head confinement.
Journal of Veterinary Internal Medicine. 2024; 38: 1224–1231. (IF: 2.6 – Q1)
5. Javad Abbasi, Arasb Dabbagh Moghaddam, Mohammad Hashemi, Sirous Sadeghian
Chaleshtori, Ali Khanjari. Improvement of the Immune System with Two Types of
Emergency Rations in the Murine Animal Model. Journal of Nutrition, Fasting and Health.
2023; 11(4): 260-267
6. Alireza Vajhi, Mohammad Reza Mokhber- Dezfouli, omid zehtabvar, Sirous Sadeghian
Chaleshtori, Seyyed Hossein Modarres Tonekabony, Reihaneh Soflaei, Javad Abbasi.
Normal Computed Tomography and radiographic Study of the Nasal Cavity and Paranasal
Sinuses in Shal Sheep (Ovis arries). Iranian Journal of Veterinary Surgery. 2023; 18(2), 133-
144.
7. Afshin Noori, Mohamad Reza Mokhber Dezfouli, Sarah Rajabi, Fatemeh Ganji, Zahra
Ghezelayagh, Elie El Agha, Hossein Baharvand, Sirous Sadeghian Chaleshtori*, Yaser
Tahamtani. Decellularized Lung Extracellular Matrix Scaffold Promotes Human Embryonic
Stem Cell Differentiation towards Alveolar Progenitors. Cell Journal. 2023; 25 (6), 372-382.
(IF: 3.2 – Q3)
8. Masomeh Jabbari Fakhr, Mohamad Reza Mokhber Dezfouli, Sirous Sadeghian
Chaleshtori*. Animal Models and Methods of Myocardial Infarction Induction and theRole
of Tissue Engineering in the Regeneration of Damaged Myocardium. Current Stem Cell
research & Therapy. 2023: 18, 676-689. (IF: 3.7 – Q3)
9. Sirous Sadeghian Chaleshtori*, Mohamad Reza Mokhber Dezfouli, Mohammad hasan Naji
zadeh, Gholamreza Nikbakht Brujeni. Measurement of ANP, BNP and endothelin-1
concentrations in jumping horses with heart valvular regurgitation and their correlation with
the dimensions of heart structures. Equine Veterinary Education. 2022; 1-11. (IF: 1.2 – Q2)
10. Mohamad Reza Mokhber Dezfouli, Faisal Zarghami Faisal, Sadegh Rahbari, Elahe
Ebrahimzadeh Abkooh, Samad Lotfollahzadeh, Sirous Sadeghian Chaleshtori, Parviz
Shayan. Protection of Calves Against Cryptosporidiosis by Hyperimmunization of Pregnant
Cattle Colostrum Using Oocyst Whole Antigens. Iranian Journal of Veterinary Medicine.
2022; 16(4), 380-389.